Boehringer Ingelheim launches AI centre for pharma research in London
Boehringer Ingelheim invests £150 million over 10 years to launch an AI research center in London aimed at accelerating pharmaceutical drug discovery. This facility serves as the company's fourth glob
reuters · 2026-04-20 05:10 UTC